ALBO - Albireo Pharma GAAP EPS of -$2.19 misses by $0.39 revenue of $6.83M misses by $0.42M May, 16 2022 04:24 PM Albireo Pharma Inc. Albireo Pharma press release (NASDAQ:ALBO): Q1 GAAP EPS of -$2.19 misses by $0.39. Revenue of $6.83M (+248.5% Y/Y) misses by $0.42M. For further details see: Albireo Pharma GAAP EPS of -$2.19 misses by $0.39, revenue of $6.83M misses by $0.42M